• DOI:10.1046/j.1365-2710.2003.00463.x
Corpus ID: 8326758

Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo‐controlled trial

@article{Akhondzadeh2003SalviaOE,
  title={Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo‐controlled trial},
  author={S. Akhondzadeh and M. Noroozian and M. Mohammadi and S. Ohadinia and A. Jamshidi and M. Khani},
  journal={Journal of Clinical Pharmacy and Therapeutics},
  year={2003},
  volume={28}
}

• S. Akhondzadeh, M. Noroozian, +3 authors M. Khani
• Published 2003
• Medicine
• Journal of Clinical Pharmacy and Therapeutics

Background:  Alzheimer's disease is characterized by a slow, progressive decline in cognitive function and behaviour. Acetylcholine esterase inhibitors are the only agents approved by the Food and Drug Administration for the treatment of Alzheimer's disease. All other agents prescribed for the treatment of Alzheimer's disease are used on an off‐label basis. Current research into new drugs is focused on agents that will prevent, slow down and/or halt the progress of the disease process. Savia… Expand

View on Wiley

tahomaclinic.com

Save to Library

Create Alert

Cite

Launch Research Feed